| Revenue | 21,921.45a | 24,163.67a |
| Cost of sales excluding impairment losses on property, plant and equipment (PPE) | -18,055.45a | -17,697.5a |
| Gross profit excluding impairment losses on PPE | 3,866a | 6,466.17a |
| Cost of sales - impairment losses on PPE | -392.86a | 0a |
| Gross profit | 3,473.14a | 6,466.17a |
| Other income | 273.88a | 336.41a |
| Other losses - net | -258.43a | -208.24a |
| Selling and marketing expenses | -126.96a | -96.87a |
| Administrative and other operating expenses | -1,019.35a | -1,091.47a |
| Net impairment losses on financial and contract assets | -15.56a | -9.05a |
| Operating profit | 2,326.72a | 5,396.95a |
| Finance income | 23.28a | 31.07a |
| Finance costs | -432.11a | -348.7a |
| Share of net profits of investments accounted for using the equity method | 17.41a | 25.53a |
| Profit before income tax | 1,935.3a | 5,104.85a |
| Income tax expense | -526.23a | -797.17a |
| Profit for the year | 1,409.07a | 4,307.68a |
| Profit for the year attributable to | — | — |
| The equity holders of the company | 1,008.23a | 3,842.76a |
| Non-controlling interests | 400.84a | 464.92a |